
    
      The drug being tested in this study is called Ixazomib (NINLARO). Ixazomib is being tested to
      treat people who have relapsed/refractory multiple myeloma. This study will look at the
      safety of NINLARO in participants with relapsed/refractory multiple myeloma in daily clinical
      practice.

      The study will enroll approximately 480 patients.

      â€¢ Ixazomib 4 mg

      This multi-center trial will be conducted in Japan.
    
  